下一个

自动播放

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 意见 • 07/14/23
分享
嵌入
administrator
administrator
订户
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放